Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-052349
Filing Date
2018-09-26
Accepted
2018-09-26 18:29:19
Documents
1
Period of Report
2018-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 15329
  Complete submission text file 0001209191-18-052349.txt   16658
Mailing Address 4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121
Business Address
Petree Daniel H (Reporting) CIK: 0001294939 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38662 | Film No.: 181089061

Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA INC (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)